{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:19:27Z","timestamp":1787019567750,"version":"build-2736575974"},"reference-count":25,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Mobilized peripheral blood is increasingly used as the source of hematopoietic stem cells for allogeneic transplantation, currently the only curative approach for sickle cell anemia. However, the safety and feasibility of stem cell mobilization in individuals with sickle cell trait (SCT) has not been documented. This study is a prospective controlled trial to evaluate the safety and feasibility of peripheral blood stem cell (PBSC) mobilization in 8 SCT subjects and 8 control subjects matched for age and race. Mobilization with filgrastim 10 \u03bcg\/kg subcutaneous daily for 5 days was followed by 12-L apheresis on the fifth day. Filgrastim administration was accompanied by similar symptoms in all subjects; no untoward adverse events occurred in either group, including sickle cell crises. CD34+ cell mobilization response was not significantly different between SCT and control subjects. Median CD34+ cell content was also similar in PBSCs collected from SCT versus control subjects, 6.8 versus 3.9 \u00d7106 CD34+ cells\/70 kg,P\u2009=\u2009.165. Red cell depletion from SCT products was not possible by using hydroxyethyl starch sedimentation but was achievable with ammonium chloride lysis. There was no evidence of gelling of SCT products after thaw, and no difference in cell recovery was seen among red cell\u2013depleted versus nondepleted products. Cryopreservation in 5% dimethyl sulfoxide\/6% pentastarch was associated with superior cell recovery (both SCT and control subjects) compared with 10% dimethyl sulfoxide (P = .001). The study concluded that filgrastim mobilization, large volume apheresis, processing, and cryopreservation appears to be safe in donors with SCT, allowing PBSC use for transplantation in patients with sickle cell anemia.<\/jats:p>","DOI":"10.1182\/blood.v99.3.850","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T08:46:40Z","timestamp":1027759600000},"page":"850-855","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":65,"title":["Mobilization, collection, and processing of peripheral blood stem cells in individuals with sickle cell trait"],"prefix":"10.1182","volume":"99","author":[{"given":"Elizabeth M.","family":"Kang","sequence":"first","affiliation":[{"name":"From the Molecular and Clinical Hematology Branch, National Institute of Diabetes, and Digestive and Kidney Disorders, and the Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M.","family":"Areman","sequence":"additional","affiliation":[{"name":"From the Molecular and Clinical Hematology Branch, National Institute of Diabetes, and Digestive and Kidney Disorders, and the Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"David-Ocampo","sequence":"additional","affiliation":[{"name":"From the Molecular and Clinical Hematology Branch, National Institute of Diabetes, and Digestive and Kidney Disorders, and the Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Fitzhugh","sequence":"additional","affiliation":[{"name":"From the Molecular and Clinical Hematology Branch, National Institute of Diabetes, and Digestive and Kidney Disorders, and the Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Link","sequence":"additional","affiliation":[{"name":"From the Molecular and Clinical Hematology Branch, National Institute of Diabetes, and Digestive and Kidney Disorders, and the Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Read","sequence":"additional","affiliation":[{"name":"From the Molecular and Clinical Hematology Branch, National Institute of Diabetes, and Digestive and Kidney Disorders, and the Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan F.","family":"Leitman","sequence":"additional","affiliation":[{"name":"From the Molecular and Clinical Hematology Branch, National Institute of Diabetes, and Digestive and Kidney Disorders, and the Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Griffin P.","family":"Rodgers","sequence":"additional","affiliation":[{"name":"From the Molecular and Clinical Hematology Branch, National Institute of Diabetes, and Digestive and Kidney Disorders, and the Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Tisdale","sequence":"additional","affiliation":[{"name":"From the Molecular and Clinical Hematology Branch, National Institute of Diabetes, and Digestive and Kidney Disorders, and the Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021215494402700_B1"},{"key":"2020021215494402700_B2","first-page":"15","article-title":"Is sickle cell trait harmless?","volume":"38","author":"Mentzer","year":"1992","journal-title":"Resid Staff Physician."},{"key":"2020021215494402700_B3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/ajh.2830270111","article-title":"Sickle cell trait in a white Jewish family presenting as splenic infarction at high altitude.","volume":"27","author":"Shalev","year":"1988","journal-title":"Am J Hematol."},{"key":"2020021215494402700_B4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0046-8177(91)90242-H","article-title":"Crisis in sickle cell trait.","volume":"22","author":"Dudley","year":"1991","journal-title":"Hum Pathol."},{"key":"2020021215494402700_B5","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/00007611-198408000-00031","article-title":"Morbidity of sickle cell trait at high altitude.","volume":"77","author":"Nussbaum","year":"1984","journal-title":"South Med J."},{"key":"2020021215494402700_B6","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1001\/jama.1985.03350390093033","article-title":"Splenic syndrome at mountain altitudes in sickle cell trait: its occurrence in nonblack persons.","volume":"253","author":"Lane","year":"1985","journal-title":"JAMA."},{"key":"2020021215494402700_B7","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(05)60614-9","article-title":"Granulocytosis causing sickle-cell crisis [letter].","volume":"351","author":"Abboud","year":"1998","journal-title":"Lancet."},{"key":"2020021215494402700_B8","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease: life expectancy and risk factors for early death.","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med."},{"key":"2020021215494402700_B9","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1182\/blood.V97.10.3313","article-title":"Fatal sickle cell crisis after granulocyte colony-stimulating factor administration.","volume":"97","author":"Adler","year":"2001","journal-title":"Blood."},{"key":"2020021215494402700_B10","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1182\/blood.V97.12.3998","article-title":"Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell\/beta+ thalassemia.","volume":"97","author":"Grigg","year":"2001","journal-title":"Blood."},{"key":"2020021215494402700_B11","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1046\/j.1537-2995.1996.36796323059.x","article-title":"Treatment of normal individuals with granulocyte-colony-stimulating factor: donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells.","volume":"36","author":"Stroncek","year":"1996","journal-title":"Transfusion."},{"key":"2020021215494402700_B12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1046\/j.1537-2995.1997.37597293882.x","article-title":"Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim.","volume":"37","author":"Anderlini","year":"1997","journal-title":"Transfusion."},{"key":"2020021215494402700_B13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ajh.2830100309","article-title":"Freeze preservation of sickle erythrocytes.","volume":"10","author":"Castro","year":"1981","journal-title":"Am J Hematol."},{"key":"2020021215494402700_B14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1046\/j.1537-2995.1976.16677060246.x","article-title":"Freezing and deglycerolizing sickle-trait red blood cells.","volume":"16","author":"Meryman","year":"1976","journal-title":"Transfusion."},{"key":"2020021215494402700_B15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ajh.2830210409","article-title":"Autologous survival of cyanate-treated cryopreserved sickle erythrocytes.","volume":"21","author":"Castro","year":"1986","journal-title":"Am J Hematol."},{"key":"2020021215494402700_B16","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/pgmj.63.738.257","article-title":"\u2018Neutropenia\u2019 in black west Indians.","volume":"63","author":"Zezulka","year":"1987","journal-title":"Postgrad Med J."},{"key":"2020021215494402700_B17","first-page":"S21","article-title":"Mobilization and collection of allogeneic peripheral blood progenitor cells for transplantation.","volume":"21(suppl 3)","author":"Wiesneth","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"2020021215494402700_B18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000208316","article-title":"Red cell life span in sickle cell trait.","volume":"51","author":"Barbedo","year":"1974","journal-title":"Acta Haematol."},{"key":"2020021215494402700_B19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1537-2995.1985.25185116509.x","article-title":"Long-term cryopreservation of red cells from patients with sickle cell disease.","volume":"25","author":"Castro","year":"1985","journal-title":"Transfusion."},{"key":"2020021215494402700_B20","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood.V88.8.3223.bloodjournal8883223","article-title":"CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies.","volume":"88","author":"Mavroudis","year":"1996","journal-title":"Blood."},{"key":"2020021215494402700_B21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.","volume":"344","author":"Bensinger","year":"2001","journal-title":"N Engl J Med."},{"key":"2020021215494402700_B22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.bmt.1702707","article-title":"Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor: a long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood.","volume":"26","author":"Kato","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"2020021215494402700_B23","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.bmt.1701234","article-title":"Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation.","volume":"21","author":"Schmitz","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"2020021215494402700_B24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bmt.1701906","article-title":"Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation.","volume":"24","author":"Mahmoud","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"2020021215494402700_B25","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(00)02090-0","article-title":"Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial.","volume":"355","author":"Powles","year":"2000","journal-title":"Lancet."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/3\/850\/1680444\/850.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/3\/850\/1680444\/850.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T15:49:53Z","timestamp":1581522593000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/3\/850\/53517\/Mobilization-collection-and-processing-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2,1]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,2,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.3.850","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2,1]]}}}